Water-soluble compounds in the herbal preparation Abana inhibit lipid biosynthesis and enhance cholesterol efflux in HepG2 cells

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 4, 2010, Pages 456-464

  Vidyashankar, Satyakumar ^a   Godavarthi, Ashok ^a   Varma, R Sandeep ^a   Nandakumar, Krishna S ^a  

^a Himalaya Health Care   (India)

Author keywords

Abana; Cholesterol; Cholesterol efflux; Fatty acid; HMG CoA; Triglyceride

Indexed keywords

ABANA; ARACHIDONIC ACID; CHOLESTEROL; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LINOLEIC ACID; TRIACYLGLYCEROL; WATER; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A; ACETIC ACID DERIVATIVE; ACYL COENZYME A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PLANT EXTRACT;

ARTICLE; ATHEROSCLEROSIS; CATABOLISM; CELL STRAIN HEPG2; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; HERBAL MEDICINE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LIPOGENESIS; PRIORITY JOURNAL; SUPERNATANT; AYURVEDA; BIOSYNTHESIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HEPG2 CELL LINE; METABOLISM; MICROSOME; SOLUBILITY;

ACETATES; ACYL COENZYME A; CELL SURVIVAL; CHOLESTEROL; FATTY ACIDS; HEP G2 CELLS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MEDICINE, AYURVEDIC; MICROSOMES; PLANT EXTRACTS; SOLUBILITY; TRIGLYCERIDES;

EID: 77952013975     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y10-021     Document Type: Article

References (35)

1. Agheli, N., and Jacotot, B. 1991. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br. J. Clin. Pharmacol. 32(4): 423-428. PMID:1958434.
2. Alberts, A.W. 1988. HMG-CoA reductase inhibitors: the development. Atheroscler. Rev. 18: 123-131.
3. Antani, J.A., Kulkarni, R.D., and Antani, N.J. 1990. Effect of Abana on ventricular function in ischemic heart disease. Jpn. Heart J. 31(6): 829-835. PMID:2084279.
4. Baliga, M.S., Jagetia, G.C., Venkatesh, P., Reddy, R., and Ulloor, J.N. 2004. Radioprotective effect of abana, a polyherbal drug following total body irradiation. Br. J. Radiol. 77(924): 1027-1035. doi:10.1259/bjr/83720350. PMID:15569645.
5. Berrougui, H., Cloutier, M., Isabelle, M., and Khalil, A. 2006. Phenolic-extract from argan oil (Argania spinosa L.) inhibits human low-density lipoprotein (LDL) oxidation and enhances cholesterol efflux from human THP-1 macrophages. Atherosclerosis, 184(2): 389-396. doi:10.1016/j.atherosclerosis. 2005.05.018.PMID:16019008. (Pubitemid 43049725)
6. Brown, M.S., Faust, J.R., Goldstein, J.L., Kaneko, I., and Endo, A. 1978. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J. Biol. Chem. 253(4): 1121-1128. PMID:624722.
7. Dadkar, V.N., Tahiliani, R.R., Jaguste, V.S., Damle, V.B., and Dhar, H.L. 1990. Double blind comparative trial of Abana and methyldopa for monotherapy of hypertension in Indian patients. Jpn. Heart J. 31(2): 193-199. PMID:2192099.
8. 2 cells. J. Biol. Chem. 267(10): 7160-7169. PMID:1313035.
9. Folch, J., Lees, M., and Sloane Stanley, G.H. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226(1): 497-509. PMID:13428781.
10. Girona, J., LaVille, A.E., Solà, R., Motta, C., and Masana, L. 2003. HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages. Biochim. Biophys. Acta, 1633(3): 143-148. PMID:14499733.
11. Goldstein, J.L., and Brown, M.S. 1990. Regulation of the mevalonate pathway. Nature (Lond.), 343(6257): 425-430. doi:10.1038/343425a0. PMID:1967820.
12. Hochgraf, E., Levy, Y., Aviram, M., Brook, J.G., and Cogan, U. 1994. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism, 43(1): 11-17. doi:10.1016/0026-0495(94)90151-1. PMID:8289667.
13. Hrboticky, N., Tang, L., Zimmer, B., Lux, I., and Weber, P.C. 1994. Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines. J. Clin. Invest. 93(1): 195-203. doi:10.1172/JCI116945. PMID:8282787.
14. Hulcher, F.H., and Oleson, W.H. 1973. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl coenzymeA reductase by measurement of coenzyme A. J. Lipid Res. 14(6): 625-631. PMID:4147523.
15. Jagetia, G.C., and Aruna, R. 1997. The herbal preparation abana protects against radiation-induced micronuclei in mouse bone marrow. Mutat. Res. 393(1-2): 157-163. PMID:9357573.
16. Jagetia, G.C., Baliga, M.S., Aruna, R., Rajanikant, G.K., and Jain, V. 2003. Effect of abana (a herbal preparation) on the radiation-induced mortality in mice. J. Ethnopharmacol. 86(2-3): 159-165. doi:10.1016/S0378-8741(03)00037-0. PMID:12738080.
17. 2 cells a resource for metabolic studies: lipoprotein, cholesterol and bile acids. FASEB J. 4: 161-168.
18. Kaneko, I., Hazama-Shimada, Y., and Endo, A. 1978. Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur. J. Biochem. 87(2): 313-321. doi:10.1111/j.1432-1033.1978.tb12380.x. PMID:668696.
19. Kinsella, J.E., Lokesh, B., and Stone, R.A. 1990. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 52(1): 1-28. PMID:2193500.
20. Kritharides, L., Christian, A., Stoudt, G., Morel, D., and Rothblat, G.H. 1998. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 18(10): 1589-1599. PMID:9763531.
21. Morrison, W.R., and Smith, L.M. 1964. Preparation of fatty acid methyl esters and dimethyl acetyls from lipids with boron trifluoride methanol. J. Lipid Res. 5: 600-608. PMID:14221106.
22. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65(1-2): 55-63. doi:10.1016/0022-1759(83)90303-4. PMID:6606682.
23. Owen, J.S. 1999. Role of ABC1 gene in cholesterol efflux and atheroprotection. Lancet, 354(9188): 1402-1403. doi:10.1016/S0140-6736(99)00297- 4. PMID:10543661.
24. Pachori, S.B., Gupta, M., and Pant, M.C. 1993. Effect of Abana and metoprolol on serum lipid profile in rabbits fed hyperlipidemic diet Ind. J. Physiol. Pharmacol. 37: 252-254.
25. Pasnani, J.S., Hemavathi, K.G., Gulati, O.D., and Rajani, A.P. 1988. Effects of Abana, an ayurvedic preparation, on rabbit atrium and intestine. J. Ethnopharmacol. 24(2-3): 287-302. doi:10.1016/0378-8741(88)90158-4. PMID:3253495.
26. Sasikumar, C.S., and Devi, C.S. 2000. Effect of abana an ayurvedic formulation, on lipid peroxidation in experimental myocardial infarction in rats. Indian J. Exp. Biol. 38(8): 827-830. PMID:12557918.
27. Searcy, R.L., and Bergquist, L.M. 1960. A new color reaction for the quantitation of serum cholesterol. Clin. Chim. Acta, 5(2): 192-199. doi:10.1016/0009-8981(60)90035-8. PMID:14444356.
28. Shapiro, D.J., and Rodwell, V.W. 1971. Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis. J. Lipid Res. 246: 3210-3216.
29. Tandon, S., Rastogi, R., and Kapoor, N.K. 1995. Protection by Abana, a herbomineral preparation against myocardial necrosis in rats-induced by isoproterenol. Phytother. Res. 10(3): 263-265. doi:10.1002/(SICI)1099- 1573(199605) 10:3〈263::AID-PTR814〉3.0.CO;2-U.
30. Tiwari, A.K., Gode, J.D., and Dubey, G.P. 1993. Influence of Abana on experimental atherogenesis in hypercholesterolemic rabbits. Jpn. Heart J. 34(4): 451-458. PMID:8246351.
31. van Doormaal, J.J., Bos, W.J., Muskiet, F.A., and Doorenbos, H. 1989. Simvastatin influences linoleic acid metabolism. Pharm. Weekbl. Sci. 11(4): 134-135. PMID:2798037.
32. Williams, M.L., Menon, G.K., and Hanley, K.P. 1992. HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes. J. Lipid Res. 33(2): 193-208. PMID:1569372.
33. 2 cells. Curr. Ther. Res. 57: 787-795.
34. 2 cells. Clin. Ther. 16(2): 200-208. PMID:8062316.
35. Yegnanarayan, R., Sangle, S.A., Sirsikar, S.S., and Mitra, D.K. 1997. Regression of cardiac hypertrophy in hypertensive patients: comparison of Abana with propranolol. Phytother. Res. 11(3): 257-259. doi:10.1002/(SICI)1099- 1573(199705) 11:3〈257::AID-PTR79〈3.0.CO;2-U.